Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Omicron thwarts some of the world’s most-used COVID vaccines

Inactivated-virus vaccines elicit few, if any, infection-blocking antibodies — but might still protect against severe disease.
  1. Elie Dolgin

    1. Elie Dolgin is a science journalist in Somerville, Massachusetts.

    View author publications

    You can also search for this author in PubMed  Google Scholar

The world’s most widely used COVID-19 vaccines provide little to no protection against infection with the rapidly spreading Omicron variant, laboratory evidence suggests.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 601, 311 (2022)

doi: https://doi.org/10.1038/d41586-022-00079-6

Updates & Corrections

  • Correction 13 January 2022: The original version of the graphic showed an incorrect number of vaccine doses delivered in the ‘Other’ category. This has now been corrected.

References

  1. Lu, L. et al. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab1041 (2021).

    Article  Google Scholar 

  2. Medigeshi, G. et al. Preprint at medRxiv https://doi.org/10.1101/2022.01.04.22268747 (2022).

  3. Ai, J. et al. Emerg. Microbe. Infect. https://doi.org/10.1080/22221751.2021.2022440 (2021).

    Article  Google Scholar 

  4. Yu, X. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.17.21267961 (2021).

  5. Bartsch, Y. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.24.21268378 (2021).

  6. Zuo, F. et al. Preprint at medRxiv https://doi.org/10.1101/2022.01.04.22268755 (2022).

  7. Wang, X. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.24.474138 (2021).

  8. AlKaabi, N. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.29.21268499 (2022).

  9. Pérez-Then, E. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.27.21268459 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links